Standard operating procedure for the preparation of ESUAvet annual reports
Standard operating procedure for the preparation of ESUAvet annual reports
Standard operating procedure for the preparation of ESUAvet annual reports
PSUSA/00010298/202603
PSUSA/00010649/202602
Human medicines European public assessment report (EPAR): Entacapone Orion, entacapone, Date of authorisation: 18/08/2011, Revision: 12, Status: Authorised
Human medicines European public assessment report (EPAR): Odomzo, sonidegib, Date of authorisation: 14/08/2015, Revision: 12, Status: Authorised
Human medicines European public assessment report (EPAR): Sotyktu, deucravacitinib, Date of authorisation: 24/03/2023, Revision: 8, Status: Authorised
EMA/PE/0000249207
Opinion/decision on a Paediatric investigation plan (PIP): Veoza, fezolinetant, decision type: W: decision granting a waiver in all age groups for all conditions or indications, therapeutic area: Vascular disorders, PIP number: EMA/PE/0000256262
EMA/PE/0000261407
Opinion/decision on a Paediatric investigation plan (PIP): Fycompa, perampanel, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Nervous system disorders, PIP number: EMA/PE/0000254635